66,293 results on '"dengue"'
Search Results
2. A Study of JNJ-64281802 for the Prevention of Dengue Infection
3. A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult Participants
4. Citizen Action for Sustainable Dengue Control in Sub-Saharan Africa
5. The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return Travelers
6. A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)
7. A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia (PRIME-Q)
8. Efficacy of Fresh Frozen Plasma (FFP) in Treating Thrombocytopenia in Dengue Patients (EFFP-TDP)
9. Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
10. Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine
11. Study to Examine the Effects of Oral Fenretinide (PROTECT)
12. A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
13. Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At Scale
14. Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan-DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181-002)
15. Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue Vaccine
16. Introduction of New Dengue Virus Lineages of Multiple Serotypes after COVID-19 Pandemic, Nicaragua, 2022.
17. Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island (DENGUE-RUN)
18. Adaptive Dengue Antiviral Platform Trial (ADAPT)
19. Dengue Controlled Human Infection Model in Dhaka, Bangladesh
20. Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE) (ZAP-DENGUE)
21. A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever
22. Reanalysis of cluster randomised trial data to account for exposure misclassification using a per-protocol and complier-restricted approach.
23. The inflammasome pathway is activated by dengue virus non-structural protein 1 and is protective during dengue virus infection.
24. Dengue Dynamics in Bangladesh: Unveiling Insights Through Statistical and Machine Learning Analysis
25. Proteome Analysis for Inflammation Related to Acute and Convalescent Infection.
26. Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype.
27. Increasing transmission of dengue virus across ecologically diverse regions of Ecuador and associated risk factors.
28. Socioeconomic and environmental factors associated with dengue fever incidence in Guatemala: Rising temperatures increase dengue risk.
29. Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children (TIDES)
30. Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose
31. Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)
32. Dengue Vaccine Hesitancy Among International Travelers
33. Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating
34. A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India
35. Expansion of a Dengue-1 Live Virus Human Challenge
36. Dengue 3 Human Infection Model (DENV-3)
37. Characterizing Humoral Immune Response to Mosquito Bites (SG6)
38. Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
39. Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4)
40. Anakinra in Dengue With Hyperinflammation ( AnaDen )
41. Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune Adults
42. Identification of Risk Determinants of Dengue Transmission Through Landscape Analysis (IRDDENGUELA)
43. Geospatial-temporal Analysis of Dengue Fever Based on the Bayesian Spatiotemporal Model.
44. Neutrophils – an understudied bystander in dengue?
45. Dengue Outbreak Caused by Multiple Virus Serotypes and Lineages, Colombia, 2023-2024.
46. Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.
47. Boric acid toxic sugar bait suppresses male Aedes aegypti (Diptera: Culicidae): wing beat frequency and amplitude, flight activity, fecundity, insemination, and mate‐finding Allee effect.
48. Discovery of Potent Degraders of the Dengue Virus Envelope Protein.
49. Dengue virus surveillance in Nepal yields the first on-site whole genome sequences of isolates from the 2022 outbreak.
50. Estimating dynamics of dengue disease in Colombo district of Sri Lanka with environmental impact by quantifying the per-capita vector density.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.